Baldwin Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
8,728
+3,358
+63% +$393K 0.11% 103
2026
Q1
$646K Hold
5,370
0.08% 139
2025
Q4
$565K Sell
5,370
-200
-4% -$18.8K 0.06% 149
2025
Q3
$467K Hold
5,570
0.05% 158
2025
Q2
$441K Sell
5,570
-650
-10% -$51.7K 0.05% 158
2025
Q1
$558K Sell
6,220
-1,915
-24% -$179K 0.07% 144
2024
Q4
$809K Buy
8,135
+915
+13% +$94.3K 0.11% 110
2024
Q3
$820K Buy
7,220
+100
+1% +$11.9K 0.1% 121
2024
Q2
$881K Hold
7,120
0.12% 115
2024
Q1
$939K Hold
7,120
0.13% 111
2023
Q4
$776K Buy
7,120
+550
+8% +$57.1K 0.12% 109
2023
Q3
$676K Sell
6,570
-400
-6% -$43.1K 0.11% 117
2023
Q2
$804K Hold
6,970
0.13% 108
2023
Q1
$742K Buy
6,970
+958
+16% +$103K 0.13% 112
2022
Q4
$667K Sell
6,012
-200
-3% -$20.4K 0.12% 117
2022
Q3
$535 Buy
6,212
+113
+2% +$10.1K 0.11% 127
2022
Q2
$556 Sell
6,099
-63
-1% -$5.58K 0.11% 133
2022
Q1
$506 Sell
6,162
-100
-2% -$7.88K 0.08% 154
2021
Q4
$480 Sell
6,262
-300
-5% -$23.9K 0.08% 166
2021
Q3
$493K Sell
6,562
-200
-3% -$15.2K 0.09% 151
2021
Q2
$526K Sell
6,762
-2,745
-29% -$204K 0.09% 156
2021
Q1
$699K Sell
9,507
-403
-4% -$29.7K 0.13% 126
2020
Q4
$774K Sell
9,910
-2,323
-19% -$178K 0.15% 109
2020
Q3
$968K Buy
12,233
+6,469
+112% +$507K 0.23% 78
2020
Q2
$425K Hold
5,764
0.13% 105
2020
Q1
$423K Sell
5,764
-105
-2% -$8.25K 0.15% 91
2019
Q4
$509K Hold
5,869
0.14% 106
2019
Q3
$471K Sell
5,869
-524
-8% -$42K 0.14% 107
2019
Q2
$511K Buy
6,393
+524
+9% +$40.1K 0.15% 105
2019
Q1
$466K Buy
5,869
+74
+1% +$5.54K 0.14% 103
2018
Q4
$423K Hold
5,795
0.13% 103
2018
Q3
$392K Sell
5,795
-786
-12% -$50.1K 0.11% 119
2018
Q2
$381K Buy
+6,581
New +$371K 0.12% 122
2017
Q2
Sell
-4,183
Closed -$254K 114
2017
Q1
$254K Hold
4,183
0.1% 109
2016
Q4
$235K Sell
4,183
-471
-10% -$27.6K 0.09% 110
2016
Q3
$277K Sell
4,654
-839
-15% -$49.1K 0.12% 108
2016
Q2
$302K Sell
5,493
-209
-4% -$11.1K 0.13% 98
2016
Q1
$288K Sell
5,702
-5,167
-48% -$253K 0.12% 101
2015
Q4
$548K Sell
10,869
-536
-5% -$27K 0.25% 64
2015
Q3
$538K Hold
11,405
0.24% 67
2015
Q2
$620K Sell
11,405
-271
-2% -$15.2K 0.26% 62
2015
Q1
$640K Buy
11,676
+210
+2% +$11.9K 0.25% 63
2014
Q4
$621K Sell
11,466
-105
-0.9% -$5.85K 0.24% 63
2014
Q3
$655K Hold
11,571
0.27% 61
2014
Q2
$639K Buy
11,571
+210
+2% +$11.5K 0.28% 65
2014
Q1
$615K Hold
11,361
0.27% 61
2013
Q4
$543K Sell
11,361
-158
-1% -$7.22K 0.24% 72
2013
Q3
$523K Buy
11,519
+2,401
+26% +$110K 0.25% 69
2013
Q2
$404K Buy
+9,118
New +$407K 0.2% 83

Other funds holding MRK

Baldwin Investment Management's MRK Position: Q2 2026 in Review

Baldwin Investment Management increased its Merck (MRK) stake by 63% in Q2 2026, buying an estimated $393K and bringing the position to 8,728 shares worth $1.12M. The position accounts for 0.11% of the portfolio, ranked #103.

Baldwin Investment Management first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Baldwin Investment Management held 8,728 shares of Merck worth $1.12M as of Q2 2026.
  • Baldwin Investment Management bought 3,358 Merck shares in Q2 2026, an estimated $393K.
  • Merck made up 0.11% of Baldwin Investment Management's portfolio in Q2 2026, its #103 holding.
  • Baldwin Investment Management first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.